
Royal Pines redevelopment raises major questions on the Gold Coast
The urban transformation of the Gold Coast, involving billions in public funding, has left residents in the dark. read now...

The urban transformation of the Gold Coast, involving billions in public funding, has left residents in the dark. read now...

SEOUL, South Korea, Feb. 25, 2026 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, today announced that all of its large-sized OLED panels, including those for TVs and monitors, have been recognized for their "perfect dimming technology"...

Atomos Ninja RAW 5.2-inch HDMI HDR Monitor-Recorder

A new report says the touchscreen MacBook Pro will have a Dynamic Island, but there’s no mention of Face ID.

Stretching from Al Hilal City in Fujairah to Sila in Abu Dhabi, close to the country’s border with Saudi Arabia, the Etihad Rail is expected to transport 36.5 million passengers annually by 2030

Modern, predictable systems can help governments diversify while attracting investment

Fees will be brought in for Park Road car park, however plans to charge for permits or parking at the Whitley Bay Playhouse have been dropped

Illinois utilities are also able to charge customers for outside legal services and expert witnesses used to push for rate hikes at the Illinois Commerce Commission.

Thunes joins a select group of global payments companies in pursuit of ESG excellence under the EcoVadis standards. SINGAPORE, Feb. 26, 2026 /PRNewswire/ -- Thunes, the Smart Superhighway to move money around the world, today announces it has been awarded a Bronze Medal from EcoVadis, a...
The Ford government has already given over $20M from its controversial worker training fund to Ontario Shipyards

Sensex Today | Stock Market LIVE Updates: Dragging the Nifty lower on Wednesday from a near 200-point advance was Reliance Industries. Even as the Nifty Bank fell nearly 300 points from the day's high, a recovery towards closing ensured that the Nifty ended the session in the green.
WAYNE, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced the pricing of its upsized public offering of 1,600,000 shares of its common stock at a price to the public of $125.00 per share. In addition, Palvella has granted the underwriters a 30-day option to purchase up to an additional 240,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The aggregate gross proceeds to Palvella from this offering are expected to be $200 million, before deducting underwriting discounts and commissions and other offering expenses, assuming no exercise of the underwriters’ option to purchase additional shares. All shares of common stock are being offered by Palvella. The offering is expected to close on or about February 27, 2026, subject to the satisfaction of customary closing conditions.